Sequential anticoagulation with LMWH and DOACs in cirrhotic portal vein thrombosis
Anticoagulation is associated with improved survival in patients with cirrhosis and PVT. DOACs appear safe in carefully selected patients, and sequential LMWH/DOAC therapy may offer clinical benefit, warranting confirmation in prospective studies.
Authors
- Ina Koch (ORCID: https://orcid.org/0000-0002-3621-003X)
- Myriam Heilani (ORCID: https://orcid.org/0000-0002-0948-2777)
- E Herrmann
- Albrecht Piiper (ORCID: https://orcid.org/0000-0003-0131-3669)
- Christoph Matthias
- Leon D. Grünewald
- Mate Knabe
- Stefan Zeuzem
- Chaarvee Gulia
- Melis Onay
Institutions
- Goethe University Frankfurt (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Cardiovascular Center Bethanien (DE)
- University Hospital Frankfurt (DE)
Publication Details
- Journal
- Clinics and Research in Hepatology and Gastroenterology
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1016/j.clinre.2026.102792
- Citations
- 1
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 23.38